Research Article
COVID-19 Pandemic and Its Impact on Perinatal Outcomes between Symptomatic and Asymptomatic Women
Table 3
Adverse perinatal outcomes.
| | Outcomes | All | Asymptomatic | Symptomatic | value | Rr (odds ratio 95% CI) |
| | Maternal outcomes | | Hospitalization | 11 (5.3) | 3 (2.1) | 8 (13.1) | 0.001 | 1.12 (1.02–1.24) | | Chest XRAY/CT scan (+ve findings) | 22 (10.5) | 8 (5.5) | 14 (22.5) | <0.001 | 1.22 (1.06–1.40) | | ICU admission | | 0 | 0 | | — | | Maternal death | | 0 | 0 | | — | | Composite maternal adverse outcomes | 11 (5.3) | 3 (2.1) | 8 (13.1) | <0.001 | 1.12 (1.02–1.24) |
| | Fetal/Neonatal outcomes | | Miscarriage | 2 (.9) | 1 (0.6) | 1 (1.6) | | — | | IUFD | 6 (2.8) | 4 (2.7) | 2 (3.2) | 0.842 | 1.19 (.213–6.68) | | Admission to NICU | 17 (8.2) | 10 (6.8) | 7 (11.4) | 0.232 | — | | NICU stay (days) (min-max) | 4 (0–40) | 4 (2–40) | 4 (0–33) | 0.368 | — | | Neonatal Cov19 infection | 10 (4.7) | 8 (5.9) | 2 (3.5) | 0.491 | 0.577 (.119–2.807) | | Composite fetal/neonatal adverse outcomes | 28 (13.4) | 18 (12.2) | 10 (16.1) | 0.451 | 1.37 (0.597–3.184) |
|
|
